Filtros : "2009" "Pharmacology, Biochemistry and Behavior" Removido: "Cavalheiro, Esper Abrão" Limpar

Filtros



Refine with date range


  • Source: Pharmacology, Biochemistry and Behavior. Unidade: FMRP

    Subjects: DOR (MEDIÇÃO;CONTROLE), ANALGESIA, TEGMENTO MESENCEFÁLICO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      DIAS, Quintino M. et al. Muscarinic and 'alfa IND.1' adrenergic mechanisms contribute to the spinal mediation of stimulation-induced antinociception from the pedunculopontine tegmental nucleus in the rat. Pharmacology, Biochemistry and Behavior, v. 92, n. 3, p. 488-494, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.pbb.2009.01.018. Acesso em: 30 set. 2024.
    • APA

      Dias, Q. M., Crespilho, S. F., Silveira, J. W. S., & Prado, W. A. do. (2009). Muscarinic and 'alfa IND.1' adrenergic mechanisms contribute to the spinal mediation of stimulation-induced antinociception from the pedunculopontine tegmental nucleus in the rat. Pharmacology, Biochemistry and Behavior, 92( 3), 488-494. doi:10.1016/j.pbb.2009.01.018
    • NLM

      Dias QM, Crespilho SF, Silveira JWS, Prado WA do. Muscarinic and 'alfa IND.1' adrenergic mechanisms contribute to the spinal mediation of stimulation-induced antinociception from the pedunculopontine tegmental nucleus in the rat [Internet]. Pharmacology, Biochemistry and Behavior. 2009 ; 92( 3): 488-494.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.pbb.2009.01.018
    • Vancouver

      Dias QM, Crespilho SF, Silveira JWS, Prado WA do. Muscarinic and 'alfa IND.1' adrenergic mechanisms contribute to the spinal mediation of stimulation-induced antinociception from the pedunculopontine tegmental nucleus in the rat [Internet]. Pharmacology, Biochemistry and Behavior. 2009 ; 92( 3): 488-494.[citado 2024 set. 30 ] Available from: https://doi.org/10.1016/j.pbb.2009.01.018

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024